FB2026_03 , released September 17, 2026
Human Disease Model Report: optic atrophy 12
Open Close
General Information
Name
optic atrophy 12
FlyBase ID
FBhh0001305
Disease Ontology Term
Parent Disease
Overview

This report describes optic atrophy 12 (OPA12), which is a subtype of optic atrophy; OPA12 exhibits autosomal dominant inheritance. OPA12 is one of several neurodegenerative disorders caused by mutations in AFG3L2, which encodes the catalytic subunit of the m-AAA protease, an ATP-dependent proteolytic complex of the mitochondrial inner membrane. See the report for neurodegenerative disease, AFG3L2-related (FBhh0001301) for information on experimental results using Drosophila models of this and related diseases.

[updated Jan. 2021 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: optic atrophy
Symptoms and phenotype

Optic atrophy refers to the death of the retinal ganglion cell axons that comprise the optic nerve. Optic atrophy is an end stage that arises from myriad causes of optic nerve damage anywhere along the path from the retina to the lateral geniculate. Since the optic nerve transmits retinal information to the brain, optic atrophy is associated with vision loss. Optic atrophy is somewhat of a misnomer as atrophy implies disuse and optic nerve damage is better termed optic neuropathy. [http://eyewiki.aao.org/Optic_Atrophy]

Specific Disease Summary: optic atrophy 12
OMIM report

[OPTIC ATROPHY 12; OPA12](https://omim.org/entry/618977)

Human gene(s) implicated

[AFG3-LIKE MATRIX AAA PEPTIDASE, SUBUNIT 2; AFG3L2](https://omim.org/entry/604581)

Symptoms and phenotype

Optic atrophy-12 (OPA12) is an autosomal dominant neurologic disorder characterized by slowly progressive visual impairment with onset usually in the first decade, although later onset has been reported. Affected individuals have impaired color vision, photophobia, pale optic discs, optic nerve atrophy, and decreased thickness of the retinal nerve fiber layer. Some patients may exhibit additional neurologic features, including impaired intellectual development, dystonia, movement disorders, or ataxia (summary by Caporali et al., 2020; pubmed:32219868). [from MIM:618977; 2021.01.11]

Genetics

Optic atrophy-12 (OPA12) is caused by heterozygous mutation in the AFG3L2 gene. [from MIM:618977; 2021.01.11]

Cellular phenotype and pathology
Molecular information

AFG3L2 is the catalytic subunit of the m-AAA protease, an ATP-dependent proteolytic complex of the mitochondrial inner membrane that degrades misfolded proteins and regulates ribosome assembly (summary by Koppen et al., 2007; pubmed:17101804). [from MIM:604581; 2021.01.11]

External links
Disease synonyms
OPA12
Ortholog Information
Human gene(s) in FlyBase
    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (0)
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (3)